BioCentury
ARTICLE | Company News

Novartis sales and marketing update

April 18, 2016 7:00 AM UTC

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier of early benefit assessment that there is an “indication of considerable added benefit” for Novartis’s fixed-dos...